Post-market clinical follow-up What's New

Post-market clinical follow-up under the EU MDR

Posted on by Congenius

Post-market clinical follow-up (PMCF) has become significantly more rigorous under the EU MDR to ensure enhanced patient safety following a device’s entry onto the market.

In the 5-minute guide below, our Clinical Consultant Dr. Martina Hersberger and Head of Clinical Dr. Sarah Bosshard share an overview of PMCF and its requirements, along with important advice on the essential do’s and don’ts.

Do you have a PMCF challenge? Our Clinical team is ready and happy to help – simply get in touch to start the conversation.

Related News & Knowledge

×

Request
a demo

Find out more about QMgeniuS by requesting a demo.

Simply fill out your details and click “Request a demo", then a member of the team will get back to you shortly.

Alternatively, feel free to give us a call on +41 44 741 04 04 to start the conversation. We look forward to hearing from you!

    ×

    Subscribe to our
    monthly knowledge update

    Stay informed and up to date with the latest industry news delivered direct to your inbox. You can tailor your preferences to prioritise what you'd like to hear about each month; be it MedTech news headlines, fact sheet resources on the latest regulations or longer articles covering timely topics across the wider MedTech industry.

    By clicking subscribe, you are signing up to receive a monthly newsletter from us containing MedTech news, industry insights and more from Congenius. Subscribing also gives you full access to all topical content on our website. For information on how your data is managed, see our privacy policy.